Private / Prepared for AbbVie Global Security

AbbVie is building a 24/7 global security intelligence capability.The external-signal layer should be live from day one.

Outtake supplements OSAC, Crisis24, International SOS, and internal analysts with semantic monitoring across social, fringe, dark web, image, video, and multilingual content.
Organizations protected by Outtake
OpenAI
IBM
Anthropic
NVIDIA
Lockheed Martin
Microsoft
Global external-signal footprint
X logo
Facebook logo
Instagram logo
TikTok logo
YouTube logo
Telegram logo
WhatsApp logo
Reddit logo
Threads logo
Truth Social logo
Mastodon logo
Meta logo
Bluesky logo
LinkedIn logo
Google logo
Bing logo
Dark webDomainsAds

Outtake monitors the external surfaces where threats form, coordinate, and move toward executives, facilities, and events.

01 / The capability build
24/7

AbbVie is staffing toward an intelligence-led GSOC.

Outtake can provide the external-signal layer while the organization continues building people, process, governance, and systems around it.

24/7 intelligence centerDocumented role · listing expired

Actionable intelligence for people, assets, products, and reputation

A documented Global Security Intelligence Analyst role supported incident awareness, crisis management, Protective Services, executive briefings, and measurable decision support.

AbbVie source
GSOC program growthNorth Chicago · leadership role

A central hub for incident reporting, assessment, and escalation

The Associate Director remit spans staffing, standards, systems, training, KPIs, measurable risk data, and collaboration across AbbVie Global Security.

AbbVie source
Enterprise security strategyNorth Chicago · global remit

Governance, rapid risk identification, and cross-functional alignment

The Senior Director mandate covers enterprise-wide strategy, executive relationships, innovation, metrics, and alignment under the Vice President of Global Security.

AbbVie source
02 / Why attention is rising

Public attention is accumulating across pricing, policy, events, and workforce change.

No documented direct threat to AbbVie executives or facilities surfaced in this research. These are attention and grievance signals, not incidents.

Drug-pricing scrutiny
MAY 2021

Humira and Imbruvica pricing remain durable public-anger vectors.

A House Oversight investigation accused AbbVie of exploiting the U.S. patent system and engaging in anticompetitive practices. This is documented public scrutiny, not evidence of a direct threat.

View source
Executive-event visibility
MAY 2025

An excessive-pricing hearing coincided with AbbVie’s stockholder meeting.

The Pharmaceutical Accountability Foundation’s case was heard in Amsterdam on May 9, 2025. Its announcement noted the same-day stockholder meeting and described the timing as coincidental.

View source
Federal spotlight
JAN–FEB 2026

Pricing policy keeps AbbVie and its leadership in national coverage.

AbbVie announced a $100B U.S. investment and pricing agreement with the administration, then sued HHS and CMS over Botox’s inclusion in the IRA negotiation program.

View source
Workforce change
THROUGH JUL 2026

WARN filings create a broader grievance and insider-risk context.

Publicly aggregated notices span California, Illinois, New Jersey, and Ohio, including a 2026 California filing affecting 85 positions. This is context, not an attributed incident.

View source
03 / The gaps the team already knows

Add new signal without forcing a rip-and-replace.

Conversations with members of AbbVie’s executive-protection team pointed us toward the leaders responsible for GSOC and protective intelligence. This briefing is an introduction for that wider group, not a continuation of an earlier meeting.

Outtake supplements OSAC, Crisis24, International SOS, and internal analysts. It adds continuous external signal that those teams can use in the workflows they already control.
External intelligence

Circular reporting

“Yesterday’s news today”

Coverage

No grassroots or dark web

A material blind spot

Operating model

EP and ESRM siloed

Leadership is working to connect them

Executive readiness

No reported OPSEC training

Executives and families

OSAC + external providers
Established intelligence
AbbVie GSOC + Protective Services
Analyst-controlled workflow
Outtake external signal
Continuous semantic monitoring
04 / The external-signal layer

Protective intelligence workflows. One operating view.

Explore representative workflows to see how Outtake turns continuous external signal into decision-ready context for AbbVie EP and GSOC teams.

Protective intelligence workflow

Executive Protection

Read threat signals across text, image, video, audio, and geolocation, then connect aliases, accounts, fixation, escalation, and proximity into an evidence-grade actor view.

Operational output
A dossier, not another post
View solution
01
Detect

Surface signal across text, image, video, audio, and location.

02
Connect

Link escalation, identities, infrastructure, and proximity.

03
Operationalize

Route decision-ready context into the team’s workflow.

Prepared for internal circulation

Give EP management and GSOC leadership the external view.

Request an introductory briefing tailored to AbbVie’s operating model: semantic signal, credible-threat thresholds, Teams and email workflows, daily trends, and controlled remediation.